Evidence map›Paper›PMID 42828140›Full record

ReviewFrontiers in oncology2026

Fertility preservation and reproductive outcomes in young women with breast and gynecological cancers: a new challenge for the clinician.

Giusi Santangelo, Noemi Tonti, Lucrezia Lamorgese, Tullio Golia D'Augé, Innocenza Palaia, Federica Tomao, Violante Di Donato, Giorgia Perniola, Ludovico Muzii

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giusi SantangeloDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Noemi TontiDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Lucrezia LamorgeseDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Tullio Golia D'AugéObstetrics and Gynecology Unit, Maternal and Child Department, San Pietro Fatebenefratelli Hospital, Rome, Italy.
Innocenza PalaiaDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Federica TomaoDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Violante Di DonatoDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Giorgia PerniolaDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
Ludovico MuziiDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing survival rates among young women diagnosed with cancer have shifted attention toward long-term quality-of-life issues, particularly fertility preservation and reproductive outcomes. Advances in cancer therapies have significantly improved prognosis in breast and gynecological malignancies; however, chemotherapy, radiotherapy, and radical surgery may severely compromise ovarian function and reproductive potential, leading to premature ovarian failure, infertility, and important psychological consequences. This review aims to summarize the current evidence regarding fertility preservation strategies and reproductive outcomes in young women with breast and gynecological cancers. An extensive literature review was conducted through MEDLINE, Embase, PubMed, and Cochrane databases, selected studies focusing on fertility counseling, fertility-sparing treatments, cryopreservation techniques, and reproductive outcomes in young women affected by cancer. Current evidence highlights the importance of early reproductive counseling and a multidisciplinary approach involving oncologists, gynecologists, reproductive specialists, and psychologists. Counseling should address ovarian reserve assessment, treatment-related gonadotoxicity, available fertility preservation options, and future pregnancy perspectives. Several fertility preservation strategies are currently available, including gonadotropin-releasing hormone agonists, oocyte and embryo cryopreservation, ovarian tissue cryopreservation, and fertility-sparing surgical approaches. In breast cancer, these strategies have demonstrated encouraging reproductive outcomes without compromising oncologic safety. In gynecological malignancies, conservative treatments such as hormonal therapy for endometrial cancer, conization or trachelectomy for cervical cancer, and fertility-sparing surgery for selected ovarian cancers may preserve reproductive potential in carefully selected patients. Available data suggest that pregnancy after fertility-sparing treatment is generally feasible and safe, although an increased risk of adverse obstetric outcomes, including preterm birth and low birth weight, has been reported. Despite significant progress in reproductive medicine and conservative oncologic surgery, several challenges remain unresolved, including optimal timing for pregnancy after cancer treatment, long-term follow-up strategies, and patient selection criteria. Ongoing research and multidisciplinary collaboration are essential to optimize fertility preservation protocols and improve both oncologic and reproductive outcomes in young cancer survivors.

Indexed as

breast cancercancer survivorscryopreservationfertility counselingfertility preservation strategiesfertility sparinggynecological cancer

Identifiers

PMID42828140
PMCPMC13631729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.